MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 5, 2016
- Accepted in final form December 15, 2016
- First Published January 16, 2017.
Author Disclosures
- Ryo Ogawa, MD,
- Ichiro Nakashima, MD, PhD,
- Toshiyuki Takahashi, MD, PhD,
- Kimihiko Kaneko, MD,
- Tetsuya Akaishi, MD,
- Yoshiki Takai, MD, PhD,
- Douglas Kazutoshi Sato, MD, PhD,
- Shuhei Nishiyama, MD, PhD,
- Tatsuro Misu, MD, PhD,
- Hiroshi Kuroda, MD, PhD,
- Masashi Aoki, MD, PhD and
- Kazuo Fujihara, MD, PhD
- Ryo Ogawa, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ichiro Nakashima, MD, PhD,
NONE
NONE
Received funding for a trip and speaks from Biogen Japan (2012-2016); Tanabe Mitsubishi (2012-2016); Novartis Pharma (2012-2016).
Served as an editorial board member of Multiple Sclerosis International(2010-present).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Received grant support from LSI Medience Corporation (2012-2016).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Toshiyuki Takahashi, MD, PhD,
NONE
NONE
(1)Biogen idec, speaker honoraria, (2)Cosmic corporation, speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1)Cosmic corporation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kimihiko Kaneko, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tetsuya Akaishi, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yoshiki Takai, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1)grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, #15K19473, representative, 2015-04-01 ? 2017-03-3.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Douglas Kazutoshi Sato, MD, PhD,
(1) Merck - advisory board; (1) TEVA - advisory board; (1) Shire - advisory board
NONE
(1) Speaker honoraria from Novartis, Genzyme, Merck-Serono, Biogen, TEVA, Bayer, Roche
Associate editor of Arquivos de Neuropsiquiatria (2013-present)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Ministry of Education, Culture, Sports, Science & Technology (MEXT) in Japan, Japanese Government Scholarship Program, 4 years (2010 - 2014)
NONE
(1) Grant-in-aid for scientific research from the Japan Society for the Promotion of Science (KAKENHI 15K19472) (2) Research support from CAPES/Brasil (88881.068012/2014)
NONE
NONE
NONE
NONE
NONE
NONE
- Shuhei Nishiyama, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Japan Society for the Promotion of Science (JSPS),KAKENHI Grant-in-Aid for Young Scientists(B) 16K19504, representative, 2016-2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tatsuro Misu, MD, PhD,
NONE
NONE
Speaker honoraria from Bayer Schering Pharma, Biogen Idec Japan
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labor and Welfare of Japan.
NONE
NONE
NONE
NONE
NONE
NONE
- Hiroshi Kuroda, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) The Ministry of Education, Culture, Sports, Science and Technology of Japan/a grant-in-aid for scientific research, grant number: 24592728, role: primary investigator, years: 2012-2015 (2) The Ministry of Education, Culture, Sports, Science and Technology of Japan/a grant-in-aid for scientific research, grant number: 15K10967, role: primary investigator, years: 2015-2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Masashi Aoki, MD, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Masashi Aoki has received research grants, Research on Nervous and Mental disorders, Research on Measures for Intractable Diseases, Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Ministry of Health Labor and Welfare, Grants-in-Aids for Scientific Research, an Intramural Research Grant for Neurological Psychiatric Disorders from NCNP and Grants-in-Aids for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
NONE
NONE
NONE
NONE
NONE
NONE
- Kazuo Fujihara, MD, PhD
Serves on scientific advisory boards for Bayer Schering Pharma, Biogen Idec, Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Nihon Pharmaceutical,Alexion Pharmaceuticals, Medimmune and Medical Review.
NONE
has received funding for travel and speaker honoraria from Bayer Schering Pharma, Biogen Idec, Eisai Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co., Daiichi Sankyo, and Nihon Pharmaceutical.
Serve as an editorial board member of Clinical and Experimental Neuroimmunology (2009-present) and a advisory board member of Sri Lanka journal of Neurology.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
has received research support from Bayer Schering Pharma, Biogen Idec Japan, Asahi Kasei Medical, The Chemo-Sero- Therapeutic Research Institute, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, Teijin Pharma, Chugai Pharmaceutical,Ono Pharmaceutical, Nihon Pharmaceutical, and Genzyme Japan.
funded as the investigator (2010?present) by the Grants- in-Aid for Scientific Research from the Ministry of Education, Science and Technology of Japan and as the secondary investigator by the Grants-in-Aid for Scientific Research from the Ministry of Health, Welfare and Labor of Japan (2010?present).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (R.O., I.N., T.T., K.K., T.A., Y.T., D.K.S., S.N., T.M., H.K., M.A., K.F.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.T.), Yonezawa National Hospital, Yamagata, Japan; Brain Institute (D.K.S.), The Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil; Department of Multiple Sclerosis Therapeutics (K.F.), Fukushima Medical University; and Multiple Sclerosis & Neuromyelitis Optica Center (K.F.), Southern Tohoku Research Institute for Neuroscience, Koriyama, Japan.
- Correspondence to Dr. Nakashima: nakashima{at}med.tohoku.ac.jp
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonRussell C. Dale, Esther M. Tantsis, Vera Merheb et al.Neurology - Neuroimmunology Neuroinflammation, May 22, 2014 -
Article
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disordersDouglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto et al.Neurology, January 10, 2014 -
Article
Clinical and imaging features of children with autoimmune encephalitis and MOG antibodiesAndreas Wegener-Panzer, Robert Cleaveland, Eva-Maria Wendel et al.Neurology: Neuroimmunology & Neuroinflammation, May 01, 2020 -
Article
Neuromyelitis optica spectrum disorders in children and adolescentsSilvia Tenembaum, Tanuja Chitnis, Ichiro Nakashima et al.Neurology, August 29, 2016